eli lilly

Known as: ely lilly 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-2016
0119822016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
UNLABELLED Chronic wounds are an increasing problem in our ageing population and can arise in many different ways. Over the past… (More)
  • figure 1
  • table 2
Is this relevant?
Review
2014
Review
2014
Ramucirumab (Cyramza™ [US]), a fully human immunoglobulin G1 (IgG1) monoclonal antibody that inhibits vascular endothelial growth… (More)
Is this relevant?
Review
2011
Review
2011
First of all, I have to say that the invitation to provide some thoughts on this comprehensive review of diagnoses and… (More)
Is this relevant?
2007
2007
10.1038/nrd2274 The glucagon-like peptide 1 (GLP1) receptor belongs to a group of G-protein-coupled receptors (GPCRs) that is… (More)
Is this relevant?
Review
2006
Review
2006
Declaration of interest All of the authorswere involved inthe development of a reviewon depression andpainwhich was fundedby Eli… (More)
Is this relevant?
2004
2004
In August 2004, duloxetine hydrochloride (Cymbalta; Eli Lilly), a selective serotonin- and noradrenaline-reuptake inhibitor, was… (More)
  • figure 1
  • figure 2
Is this relevant?
2002
2002
The I1 subtype of imidazoline receptors (I1R) is a plasma membrane protein that is involved in diverse physiological functions… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
1993
1993
Growth hormone (GH) therapy has been reported to cause changes in thyroid function in GH deficiency including decreases in T4 and… (More)
Is this relevant?
1982
1982
Food and Drug Administration (FDA) internal documents released this month by a House subcommittee allege that Eli Lilly and… (More)
Is this relevant?